
Sagar S. Patel
Examiner (ID: 15778, Phone: (571)272-1317 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626 |
| Total Applications | 657 |
| Issued Applications | 436 |
| Pending Applications | 84 |
| Abandoned Applications | 159 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14031151
[patent_doc_number] => 10227314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Cystathionine-gamma-lyase (CSE) inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/672511
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 28716
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672511
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/672511 | Cystathionine-gamma-lyase (CSE) inhibitors | Aug 8, 2017 | Issued |
Array
(
[id] => 14309565
[patent_doc_number] => 20190144486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => SUBSTITUTED HETEROPENTADIENO-PYRROLOPYRIMIDINE RIBONUCLEOSIDES FOR THERAPEUTIC USE
[patent_app_type] => utility
[patent_app_number] => 16/308796
[patent_app_country] => US
[patent_app_date] => 2017-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308796
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308796 | Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides for therapeutic use | Jul 30, 2017 | Issued |
Array
(
[id] => 12185409
[patent_doc_number] => 20180044344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'CDK2/4/6 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/664265
[patent_app_country] => US
[patent_app_date] => 2017-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 87582
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15664265
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/664265 | CDK2/4/6 inhibitors | Jul 30, 2017 | Issued |
Array
(
[id] => 12126149
[patent_doc_number] => 20180009735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'THERAPEUTIC COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/658219
[patent_app_country] => US
[patent_app_date] => 2017-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29506
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15658219
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/658219 | Therapeutic compounds and uses thereof | Jul 23, 2017 | Issued |
Array
(
[id] => 16999362
[patent_doc_number] => 11078152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Method for resolution of baclofen salts
[patent_app_type] => utility
[patent_app_number] => 16/318565
[patent_app_country] => US
[patent_app_date] => 2017-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 8481
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318565
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318565 | Method for resolution of baclofen salts | Jul 19, 2017 | Issued |
Array
(
[id] => 17700310
[patent_doc_number] => 11374044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Material for photoelectric conversion element for use in imaging element, and photoelectric conversion element including same
[patent_app_type] => utility
[patent_app_number] => 16/318240
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12027
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318240
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318240 | Material for photoelectric conversion element for use in imaging element, and photoelectric conversion element including same | Jul 17, 2017 | Issued |
Array
(
[id] => 12023564
[patent_doc_number] => 20170313663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'Bendamustine Derivatives and Related Compounds, and Medical Use Thereof in Cancer Therapy'
[patent_app_type] => utility
[patent_app_number] => 15/647257
[patent_app_country] => US
[patent_app_date] => 2017-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9112
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15647257
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/647257 | Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy | Jul 10, 2017 | Issued |
Array
(
[id] => 15619349
[patent_doc_number] => 20200080079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS
[patent_app_type] => utility
[patent_app_number] => 16/302018
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302018
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302018 | Processes for preparing phosphorodiamidate morpholino oligomers | Jun 29, 2017 | Issued |
Array
(
[id] => 13167913
[patent_doc_number] => 10100060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Asymmetric synthesis of funapide
[patent_app_type] => utility
[patent_app_number] => 15/625173
[patent_app_country] => US
[patent_app_date] => 2017-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20443
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15625173
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/625173 | Asymmetric synthesis of funapide | Jun 15, 2017 | Issued |
Array
(
[id] => 14467969
[patent_doc_number] => 20190185627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => USE OF 2,4-DIHALO-6-SUBSTITUTED-1,3,5-TRIAZINES AND DERIVATIVE THEREOF AS CONDENSATION, CROSS-LINKING, TANNING, GRAFTING AND CURING AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/311486
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311486
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311486 | Use of 2,4-dihalo-6-substituted-1,3,5-triazines and derivative thereof as condensation, cross-linking, tanning, grafting and curing agents | Jun 14, 2017 | Issued |
Array
(
[id] => 16476126
[patent_doc_number] => 10851053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Chemical compounds
[patent_app_type] => utility
[patent_app_number] => 16/307513
[patent_app_country] => US
[patent_app_date] => 2017-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33045
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307513
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307513 | Chemical compounds | Jun 6, 2017 | Issued |
Array
(
[id] => 15540651
[patent_doc_number] => 10570090
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/613689
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51852
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 436
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613689
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/613689 | Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof | Jun 4, 2017 | Issued |
Array
(
[id] => 14836159
[patent_doc_number] => 20190276480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS
[patent_app_type] => utility
[patent_app_number] => 16/302443
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302443
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302443 | Processes for preparing phosphorodiamidate morpholino oligomers | May 23, 2017 | Issued |
Array
(
[id] => 14119213
[patent_doc_number] => 10246453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-02
[patent_title] => Benzenesulfonamide compounds and their use as therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 15/600490
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 108216
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600490
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/600490 | Benzenesulfonamide compounds and their use as therapeutic agents | May 18, 2017 | Issued |
Array
(
[id] => 16999366
[patent_doc_number] => 11078156
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Ammoxidation reactor control
[patent_app_type] => utility
[patent_app_number] => 16/301882
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5289
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301882
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301882 | Ammoxidation reactor control | May 3, 2017 | Issued |
Array
(
[id] => 14309455
[patent_doc_number] => 20190144431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => METHOD FOR PRODUCING 5-HYDROXYALKYL-SUBSTITUTED 1-PHENYL-1,2,4- TRIAZOLE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/098238
[patent_app_country] => US
[patent_app_date] => 2017-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098238
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098238 | Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4-triazole derivatives | May 1, 2017 | Issued |
Array
(
[id] => 16276758
[patent_doc_number] => 10759772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Process for the preparation of DL-proline co-crystal of Dapagliflozin
[patent_app_type] => utility
[patent_app_number] => 16/097777
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3031
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097777
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097777 | Process for the preparation of DL-proline co-crystal of Dapagliflozin | Apr 27, 2017 | Issued |
Array
(
[id] => 11850169
[patent_doc_number] => 20170224661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'AMORPHOUS TECOVIRIMAT PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 15/498787
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6471
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498787
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/498787 | Amorphous tecovirimat preparation | Apr 26, 2017 | Issued |
Array
(
[id] => 14213649
[patent_doc_number] => 20190119209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => ACYL SULFONAMIDE NaV1.7 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/092075
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092075
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092075 | Acyl sulfonamide NaV1.7 inhibitors | Apr 18, 2017 | Issued |
Array
(
[id] => 12001999
[patent_doc_number] => 20170306155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'MEROCYANINE-BASED COMPOUNDS, AND DYES, KITS AND CONTRAST MEDIUM COMPOSITIONS FOR LABELLING BIOMOLECULES COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/490971
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 14821
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490971
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/490971 | Merocyanine-based compounds, and dyes, kits and contrast medium compositions for labelling biomolecules comprising the same | Apr 18, 2017 | Issued |